ArticleACS omega2022
Magnetic Control-Enhanced Lateral Flow Technique for Ultrasensitive Nucleic Acid Target Detection.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Surface-Enhanced Raman Spectroscopy for Viral Diagnostics: Principles, Strategies, Clinical Challenges, and Future Directions.Chemical reviews · 2026Review
- PDA-integrated Au@Ag with colorimetric/SERS dual-signal enhancement capability for flexible lateral flow immunoassay detection of respiratory viruses.Mikrochimica acta · 2025Article
- Lateral flow assays: Progress and evolution of recent trends in point-of-care applications.Materials today. Bio · 2024Review
- Dual-Modal Colorimetric and Surface-Enhanced Raman Scattering (SERS)-Based Lateral Flow Immunoassay for Ultrasensitive Detection of SARS-CoV-2 Using a Plasmonic Gold Nanocrown.Analytical chemistry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, a lateral flow (LF)-based detection strategy termed magnetic control-enhanced LFA (MCLF) was proposed to detect nucleic acid sequences at attomolar sensitivity. In the proposed MCLF method, magnetic controllers which are magnetic nanoparticles modified with antibodies against the labels on capture sequences were used to interact with the unreacted labeled capture sequence (CS-label) to improve the detection limit. By regulating the movement of magnetic probes (magnetic controllers) with a simple magnet under the lateral flow strip, the movement of magnetic probes bounded with unreacted CS-label in the sample flow could be reduced. Therefore, the target sequence-containing sandwich structures will arrive at the test zone prior, to interact with the recognition ligands, whereby the capture efficiency of the sandwich structures could be increased because the unreacted capture sequences at the test zone will be reduced. With the colorimetric signal from gold nanoparticle-based probes, the proposed MCLF technique could recognize as low as 100 aM of DNA target sequences by naked eyes, and the responding range of MCLF is from 100 aM to 10 pM.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.